Table 2.
Parameters at the peak level of C-reactive protein stratified for survival and non-survival
| Parametersa | Total (n = 250) | Survivors (n = 209) | Non-survivors (n = 41) | Estimate with 95% CIb | p valuec | Not knownd |
|---|---|---|---|---|---|---|
| C-reactive protein (mg/dl) | 18.5 (9.8–28.4) | 18.6 (10–28) | 17.6 (7.9–31.9) | − 0.13 (− 5.3 to 4.55) | 0.9491 | 0/0 |
| Fibrinogen (mg/dl) | 506 (329–675) | 518 (383–685) | 279 (173–514) | 206 (118 to 289) | < 0.0001 | 56/9 |
| Platelets (G/l) | 124 (50–232) | 147 (62.5–247) | 63 (29–98) | 74 (37 to 111) | < 0.0001 | 5/0 |
| aPTT (s) | 47 (38–56) | 46 (36–53) | 64 (53.5–83) | − 20 (− 28 to − 13) | < 0.0001 | 59/15 |
| PT (%) | 71 (51–84) | 74 (55–85) | 49 (36–71.5) | 20 (10 to 30) | 0.0001 | 59/14 |
| Antithrombin (%) | 63 (47–81) | 65.5 (50–82) | 51 (40–66) | 14 (5 to 23) | 0.0045 | 75/10 |
| Leukocytes (G/l) | 10.4 (4.6–17.8) | 11.1 (5.3–17.5) | 8.2 (3–20) | 1.4 (− 1.6 to 5.1) | 0.3342 | 4/5 |
aData are presented as medians (25th–75th percentile)
bEstimated median difference
cDifferences between survivors and non-survivors assessed with Wilcoxon rank sum test for continuous variables
dNumber of missing measurements in survivors/non-survivors